A Study of Brain Imaging With Nuclear Medicine Technology in Individuals With and at Risk for Parkinson's Disease

• Status: Completed
• Trial end date: 2013-01-01
• Target enrollment: 0
• Participant gender: All

Summary

This study involves study participants who have been clinically diagnosed with parkinsonian syndrome or who are at-risk for parkinsonian syndrome, have a family history of parkinsonian syndrome or exposure to environmental toxins potentially associated with parkinsonian syndrome. Participants will have brain imaging to assess dopamine transporter density. The imaging data coupled with family history and environmental exposure data may provide important information about potential risk factors for parkinsonian syndrome.

• Phase: Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Institute for Neurodegenerative Disorders
• Collaborators: Albany Medical College; Indiana University

Criteria

Inclusion Criteria:

• 22 years or older

• A clinical diagnosis of Parkinson's disease (PD), positive family history of PD and/or potential exposure to environmental toxins

• Normal screening laboratory studies

Exclusion Criteria:

• Pregnancy

• Psychiatric disease other than history of depression

• Significant medical disease including abnormalities on screening